In this study, we investigated how oHSV-induced IGF1R/YAP1 signaling influences feedback pro-survival and proliferative pathways in tumor cells and evaluated the therapeutic potential of combining IGF1R blockade with oHSV and RTx. This evidence concerns the gene IGF1R and neoplasm.